ROCHE FDA Approval NDA 006525

NDA 006525

ROCHE

FDA Drug Application

Application #006525

Application Sponsors

NDA 006525ROCHE

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL500MG0GANTRISINSULFISOXAZOLE

FDA Submissions

UNKNOWN; ORIG1AP1948-07-29UNKNOWN
LABELING; LabelingSUPPL15AP1978-01-27
LABELING; LabelingSUPPL16AP1978-07-12
LABELING; LabelingSUPPL17AP1982-05-25
LABELING; LabelingSUPPL18AP1997-01-09
LABELING; LabelingSUPPL20AP1993-08-04

CDER Filings

ROCHE
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 6525
            [companyName] => ROCHE
            [docInserts] => ["",""]
            [products] => [{"drugName":"GANTRISIN","activeIngredients":"SULFISOXAZOLE","strength":"500MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"GANTRISIN","submission":"SULFISOXAZOLE","actionType":"500MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.